SSM
TEVA icon

Sound Shore Management’s Teva Pharmaceuticals TEVA Stock Holding History

Sound Shore Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$129M Sell
3,804,497
-81,186
-2% -$2.7M 3.97% 1
2026
Q1 		$117M Sell
3,885,683
-424,223
-10% -$13.6M 3.92% 1
2025
Q4 		$135M Sell
4,309,906
-1,337,543
-24% -$33M 4.28% 2
2025
Q3 		$114M Sell
5,647,449
-199,063
-3% -$3.5M 3.77% 1
2025
Q2 		$98M Buy
5,846,512
+394,423
+7% +$6.36M 3.34% 7
2025
Q1 		$83.8M Buy
5,452,089
+679,377
+14% +$12.1M 2.94% 16
2024
Q4 		$105M Sell
4,772,712
-1,204,132
-20% -$21.9M 3.47% 3
2024
Q3 		$108M Sell
5,976,844
-784,602
-12% -$13.7M 3.5% 2
2024
Q2 		$110M Sell
6,761,446
-733,244
-10% -$11.3M 3.66% 1
2024
Q1 		$106M Sell
7,494,690
-1,424,544
-16% -$18M 3.31% 7
2023
Q4 		$93.1M Buy
8,919,234
+998,522
+13% +$9.32M 3.23% 8
2023
Q3 		$80.8M Buy
+7,920,712
New +$73.8M 3.09% 9

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Sound Shore Management's TEVA Position: Q2 2026 in Review

Sound Shore Management reduced its Teva Pharmaceuticals (TEVA) stake by 2.1% in Q2 2026, selling an estimated $2.7M and leaving 3,804,497 shares worth $129M. The position accounts for 3.97% of the portfolio, ranked #1.

Sound Shore Management first reported a position in TEVA in Q3 2023 and has held it in 12 quarters since. The position peaked at $135M in Q4 2025. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Sound Shore Management held 3,804,497 shares of Teva Pharmaceuticals worth $129M as of Q2 2026.
  • Sound Shore Management sold 81,186 Teva Pharmaceuticals shares in Q2 2026, an estimated $2.7M.
  • Teva Pharmaceuticals made up 3.97% of Sound Shore Management's portfolio in Q2 2026, its #1 holding.
  • Sound Shore Management first reported a position in Teva Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Sound Shore Management's Teva Pharmaceuticals position peaked at $135M in Q4 2025.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Sound Shore Management's 13F filing for Q2 2026, filed 12 Aug 2026.